bioAffinity Technologies Received Notice of Delisting
bioAffinity Technologies (BIAF) has received a delisting notice from Nasdaq because its stock failed to maintain the minimum $1.00 bid price for 30 consecutive business days. The company is ineligible for the standard compliance period due to a reverse stock split in the previous …